Ani Well Pharmaceutical Private Limited
About Ani Well Pharmaceutical Private Limited
Data last updated:
Ani Well Pharmaceutical Private Limited is a private limited company based in Jalandhar, Punjab, India. It operates in the agricultural products distribution segment of the agriculture sector. It was incorporated on 03 September 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U51900PB2014PTC038884. Its GSTIN is 03AAMCA9314L1ZI (Punjab).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Shalu (Whole-Time Director) and Manav Luthra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 495 New Ishwer Colony Kala Singhian Road Basti Sheikh, Jalandhar, Punjab, India – 144002.
As per the financials filed for FY 2024, the company reported a revenue of ₹78.71 Lakh, a growth of 16% compared to the previous year. For the same year it recorded a net loss of ₹26,836 (net margin -0.3%) and EBITDA of ₹67,406 (EBITDA margin 0.9%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 33% over five years.
Court records list 3 cases involving the company, including 3 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Ani Well Pharmaceutical Private Limited's registered office is in Jalandhar, Punjab. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address495 New Ishwer Colony Kala Singhian Road Basti Sheikh, Jalandhar, Punjab, India – 144002
- IndustryAgriculture, Agro Retail & Distribution
To see the full contact details of Ani Well Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ani Well Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Ani Well Pharmaceutical Private Limited, buy the company report.
Financials of Ani Well Pharmaceutical Private Limited
FY 2025 filings availableAni Well Pharmaceutical Private Limited reported revenue of ₹78.71 Lakh (up 16% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 33% over five years, including 16% growth in the latest year. EBITDA fell 63% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹67,406 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹26,836 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.9% | ||||
| Net Profit Margin | -0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ani Well Pharmaceutical Private Limited, buy the company report.
Board of directors of Ani Well Pharmaceutical Private Limited
Ani Well Pharmaceutical has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manav Luthra | Director | 18 Feb 2016 | 10 Years 8 Months | Current |
| Shalu | Whole-Time Director | 12 Apr 2015 | 11 Years 6 Months | Current |
Auditor
Ani Well Pharmaceutical Private Limited is audited by SUNIL KASTURIA & CO. for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SUNIL KASTURIA & CO. | FY 2021 | 025189N |
Shareholding
The shareholding of Ani Well Pharmaceutical Private Limited is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Ani Well Pharmaceutical Private Limited, buy the company report.
Legal cases
Ani Well Pharmaceutical Private Limited has 3 court cases on record: 3 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 3 | 0 |
Cases on record (2 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed against the company by Zenex Animal Health India Pvt Ltd | Disposed |
| District court, Ahmedabad, Gujarat | Court case (CR EN) | Filed against the company by Zenex Animal Helath India Pvt Ltd | Disposed |
To see the full case history of Ani Well Pharmaceutical Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ani Well Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ani Well Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 03AAMCA9314L1ZI | Punjab | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Ani Well Pharmaceutical Private Limited, buy the company report.
Recent activity
Ani Well Pharmaceutical Private Limited has 6 board changes on record since 2014: 4 appointments and 2 cessations. The latest: Pradeep ceased to be Director on 20 Feb 2016.
Frequently asked questions
Ani Well Pharmaceutical is an active private limited company based in Jalandhar, Punjab, India. The company works in agro retail and distribution, within the agriculture industry. It was incorporated on 03 September 2014 (12+ years old) and is registered under CIN U51900PB2014PTC038884.
Ani Well Pharmaceutical has 2 current directors:
- Shalu - Whole-Time Director
- Manav Luthra - Director
The latest financial statements of Ani Well Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Ani Well Pharmaceutical is 03AAMCA9314L1ZI, registered in Punjab.
The CIN (Corporate Identification Number) of Ani Well Pharmaceutical is U51900PB2014PTC038884. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ani Well Pharmaceutical has 3 court cases on record: 3 filed against it.
Ani Well Pharmaceutical was incorporated on 03 September 2014, making it 12+ years old. It is registered with the Registrar of Companies, Chandigarh.
Pradeep ceased to be Director on 20 Feb 2016. Manav Luthra was appointed as Director on 18 Feb 2016. Pradeep was appointed as Director on 01 Aug 2015. Ani Well Pharmaceutical has 6 board changes on record in total.
The registered office of Ani Well Pharmaceutical is at 495 New Ishwer Colony Kala Singhian Road Basti Sheikh, Jalandhar, Punjab, India – 144002.
Ani Well Pharmaceutical operates in the agriculture industry, in the agro retail and distribution segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
